UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063263
Receipt number R000072383
Scientific Title Effectiveness of an Introductory Go Program for Older Adults in Senior Living Facilities: A Nonrandomized Controlled Trial
Date of disclosure of the study information 2026/10/16
Last modified on 2026/10/13 22:45:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of an Introductory Go Program for Older Adults in Senior Living Facilities

Acronym

Go-SL Study

Scientific Title

Effectiveness of an Introductory Go Program for Older Adults in Senior Living Facilities: A Nonrandomized Controlled Trial

Scientific Title:Acronym

Go-SL Study

Region

Japan


Condition

Condition

Mental well-being and cognitive function among older adults living in senior living facilities

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of a beginner Go program consisting of 15 weekly 60-minute sessions on mental well-being and cognitive function among Go-naive adults aged 65 years or older living in residential care facilities, compared with usual care without Go training.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in the WHO-5 Well-Being Index score from baseline (immediately before the intervention period) to the assessment immediately after completion of the 15-session program

Key secondary outcomes

Changes in psychological well-being and quality of life (self-rated health, subjective happiness, satisfaction with daily life, and scores on the Japanese version of the Dementia Quality of Life Instrument [DQoL]); changes in cognitive function (MMSE-J, MoCA-J, Trail Making Test [TMT] Parts A and B, Digit Span, WMS-R Visual Memory Span, and verbal fluency); changes in physical function (Purdue Pegboard Test); and changes in Go playing proficiency in the intervention group, among other outcomes.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

An introductory Go program led by a professional Go player will be conducted at the participating facilities once a week for 60 minutes per session, for a total of 15 sessions. The program will consist of instruction on the basic rules of Go, practice exercises, and Go games. The content and difficulty level will be adjusted according to the participants' cognitive abilities.

Interventions/Control_2

Participants in the control group will continue to receive usual care without participating in the introductory Go program.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Residence in senior living facilities operated by Life Co., Ltd., including fee-based homes for older adults with long-term care services or serviced housing for older adults.
2. Age 65 years or older.
3. No prior experience learning Go.
4. Written informed consent from the participant or a legally acceptable representative (e.g., a family member or designated key person).

Key exclusion criteria

1. Unable to participate in assessments.
2. Unable to participate in Go classes.
3. Undergoing acute treatment for a psychiatric or physical illness.
4. Bedridden.
5. Scheduled to leave the residential facility before completion of all interventions and assessments.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Ai
Middle name
Last name Iizuka

Organization

Tokyo Metropolitan Institute for Geriatrics and Gerontology

Division name

Research Team for Social Participation and Healthy Aging

Zip code

173-0015

Address

35-2 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan

TEL

03-6905-6781

Email

aiizuka@tmig.or.jp


Public contact

Name of contact person

1st name Ai
Middle name
Last name Iizuka

Organization

Tokyo Metropolitan Institute for Geriatrics and Gerontology

Division name

Research Team for Social Participation and Healthy Aging

Zip code

173-0015

Address

35-2 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan

TEL

03-3964-3241

Homepage URL


Email

aiizuka@tmig.or.jp


Sponsor or person

Institute

Tokyo Metropolitan Institute for Geriatrics and Gerontology

Institute

Department

Personal name



Funding Source

Organization

Life Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Seigakuin University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Seigakuin University

Address

1-1 Tosaki, Ageo-shi, Saitama, Japan

Tel

048-781-0925

Email

m_hasebe@seigakuin-univ.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

84

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 10 Month 12 Day

Date of IRB

2023 Year 10 Month 12 Day

Anticipated trial start date

2023 Year 11 Month 15 Day

Last follow-up date

2026 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 10 Month 13 Day

Last modified on

2026 Year 10 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072383